0001567619-20-010950.txt : 20200521
0001567619-20-010950.hdr.sgml : 20200521
20200521173432
ACCESSION NUMBER: 0001567619-20-010950
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200520
FILED AS OF DATE: 20200521
DATE AS OF CHANGE: 20200521
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: O'Neil Thomas P.
CENTRAL INDEX KEY: 0001640645
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39041
FILM NUMBER: 20903009
MAIL ADDRESS:
STREET 1: SATSUMA PHARMACEUTICALS, INC.
STREET 2: 400 OYSTER POINT BOULEVARD, SUITE 221
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Satsuma Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001692830
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 813039831
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 OYSTER POINT BOULEVARD
STREET 2: SUITE 221
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 64080
BUSINESS PHONE: 415-505-0809
MAIL ADDRESS:
STREET 1: 400 OYSTER POINT BOULEVARD
STREET 2: SUITE 221
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 64080
4
1
doc1.xml
FORM 4
X0306
4
2020-05-20
0
0001692830
Satsuma Pharmaceuticals, Inc.
STSA
0001640645
O'Neil Thomas P.
C/O SATSUMA PHARMACEUTICALS, INC.
400 OYSTER POINT BOULEVARD, SUITE 221
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Financial Officer
Common Stock, $0.0001 par value
2020-05-20
4
M
0
2000
4.56
A
2000
D
Common Stock, $0.0001 par value
2020-05-20
4
S
0
2000
25
D
0
D
Stock Option (Right to Buy)
4.56
2020-05-20
4
M
0
2000
0.00
D
2029-05-16
Common Stock
2000
69340
D
Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
The option vest and become exercisable in successive, equal monthly installments over four years measured from May 15, 2019, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
/s/ Thomas P. O'Neil
2020-05-21